Opinion|Videos|February 24, 2025
Positioning Biosimilars in Clinical Practice
Panelists discuss how biosimilars are gaining traction through targeted education, cost-effectiveness analysis, and rigorous clinical validation, with providers increasingly integrating these alternatives by addressing knowledge barriers and demonstrating comparable therapeutic performance.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- How are providers positioning biosimilars in their treatment algorithms? What can be done to increase provider confidence in biosimilars?
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Ebola Cases Top 1700 as Unpaid Health Workers Strike
2
Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers
3
FDA Expands Approval for VWD Prophylaxis in Children Younger Than 6
4
Gene Therapy Could Ease Wet AMD's Injection Burden: Carl Regillo, MD
5